Aimmune Therapeutics Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Aimmune Therapeutics Inc   (NASDAQ: AIMT)

AIMT's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
(Dec 31 2015)
2015
Y / Y Equity Change -65.2 % 68.13 % -37.82 % 38.65 % -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Aimmune Therapeutics Inc 's Equity $ 104 Millions Annual AIMT's Balance sheet
Aimmune Therapeutics Inc 's Annual Income $ -248 Millions Annual AIMT's Income Statement
Where are AIMT's Income coming from? Visit AIMT's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.